CSRxP: U.S. House Adds to Unprecedented Momentum to Hold Big Pharma Accountable with Passage of Rx Solutions in Build Back Better

11-19-2021 Press Release

Congress Must Capitalize on Historic Opportunity to Lower Drug Prices, Reject Pharma-Backed Policies That Would Hike Health Care Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to the U.S. House passage of drug pricing provisions contained in the […]

CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS

11-12-2021 Press Release

Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical Benefit Will Cost Medicare Part B Outpatients $21.60 More Per Month For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on news that Medicare Part B premiums for outpatient beneficiaries will increase by […]

CSRXP APPLAUDS INCLUSION OF PRESCRIPTION DRUG PRICING SOLUTIONS IN LATEST FRAMEWORK

11-2-2021 Press Release

Congress Should Reject Pharma-backed Proposals That Would Hike Health Care Premiums, Advance Solutions to Deliver Real Rx Relief for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday reacting to the release of a drug pricing compromise package to be included […]

CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES

10-28-2021 Press Release

Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the American People For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the release of a framework from President Biden for the Build Back Better Act. “This framework fails […]

CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP

10-20-2021 Press Release

U.S. Food & Drug Administration Approval of Cyltezo Marks Second Interchangeable Biosimilar Approved by Agency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the Food and Drug Administration’s (FDA) decision Monday to approve interchangeable biosimilar Cyltezo, as an alternative to […]

CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

09-29-2021 Press Release

Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive Tactics That Undermine More Affordable Alternatives For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in advance of a U.S. House of Representatives Committee on the Judiciary mark up of two bills that […]

CSRXP POLL: MASSIVE MAJORITIES OF AMERICAN VOTERS SUPPORT SOLUTIONS TO LOWER DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

09-14-2021 Press Release

Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus Innovation Rhetoric And Say Lack of Action in Congress Would Impact Vote in Next Election For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult Tuesday. “The […]

CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE

09-14-2021 Press Release

Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for Patients, Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday on the start of legislative markups before the U.S. House Committee on Energy & Commerce and Committee on Ways & Means on policies to address out-of-control prescription drug prices. […]

CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

09-9-2021 Press Release

Administration Proposal Would Increase Competition, Transparency and Value — Reform Medicare Part D to Protect Seniors and Taxpayers Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to the release of a comprehensive plan to lower prescription drug prices from U.S. Department of Health & Human Services (HHS) Secretary Xavier […]

CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT

08-12-2021 Press Release

Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver on Repeated Promises to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to a landmark speech from President Biden calling on Congress to pass solutions to lower […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.